MG Activities of Daily Living (MG-ADL) Scale - Conquer Myasthenia Gravis

MG Activities of Daily Living (MG-ADL) Scale - Conquer Myasthenia Gravis

Price: $ 228.00

4.7(164)

With a disease like myasthenia that fluctuates from day to day and even more from month to month, it can be challenging to get a clear picture of a person’s illness. Your doctor can assess your myasthenia with several different tracking tools. One of these measures is called the MG Activities of Daily Living scale, Read more »

https://www.mg-united.com/content/experience-fragments/mg-united-us-global/language-masters/en/site/form---sign-up-full/share-story-form-full/_jcr_content/root/container_853545062_/customform/forms/container/container_copy/image.coreimg.png/1651867129561/illo-man-with-coffee.png

Been Living with MG for Some Time?

https://www.myastheniagravis.org/wp-content/uploads/2022/07/IMG_1609-e1658440951280-300x100.jpg

blog Archives - Page 3 of 16 - Conquer Myasthenia Gravis

https://www.neurology.org/cms/asset/f0d81f78-9107-4dc5-aecd-6c1a4d81ece3/wnl.2023.101.issue-10.largecover.jpg

Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials

https://www.neurology.org/cms/10.1212/WNL.0000000000207278/asset/36476a9d-e17b-437f-985e-100680ab86b0/assets/images/large/13ttu2.jpg

Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials

https://www.researchgate.net/publication/284287403/figure/tbl2/AS:669544351817729@1536643221070/2-Myasthenia-Gravis-Activities-of-Daily-Living-Scale-MG-ADL.png

2 Myasthenia Gravis Activities of Daily Living Scale (MG-ADL)

https://www.mg-united.com/content/mg-united-us-global/us/en/disease-and-treatment/been-living-with-myasthenia-gravis-for-some-time/_jcr_content/root/container/container/image.coreimg.png/1685574104190/mg-sometime-chart.png

Been Living with MG for Some Time?

https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=854656599362160

myastheniastrong

https://www.myastheniagravis.org/wp-content/uploads/2022/09/integras-p-18-1024x766.jpg

Patient Experience with Pyridostigmine - Conquer Myasthenia Gravis

https://europepmc.org/articles/PMC7042797/bin/jamaneurol-77-582-g001.jpg

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial

https://www.myastheniagravis.org/wp-content/uploads/2022/09/assessment-online-survey-6078645_1280.png

Patient Experience with Pyridostigmine - Conquer Myasthenia Gravis